Share on LinkedInShare on LinkedIn

ARTICLE · 05 OCTOBER 2007

Patenting Enantiomers – Court Decides There Is Nothing Sinister

Generally, in Australia, a single enantiomer is a patentable invention despite the existence of a patent claiming the racemic mixture.

AustraliaIntellectual Property
Nicholas Tyacke
Nicholas Tyacke
Simone Chernishev
Simone Chernishev
Author LinkedIn connections

Today, the majority of the world’s top selling pharmaceutical products have a chiral molecule as their active pharmaceutical ingredient. Increasingly, this chiral molecule is a single enantiomeric form of that molecule. As the importance of enantiomeric compounds to the pharmaceutical industry has increased, so has the number of patents that relate to such compounds. This, in turn, has led to an increasing amount of litigation with respect to such patents as the patent holders assert those patents to protect their valuable intellectual property and the revenue stream that it generates and generic manufacturers challenge those patents in order to gain access to a piece of that revenue stream.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from